Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...

A group of dedicated superintendents from small and rural school districts across the state were recently asked a straightforward question: How many were familiar with Texas’ requirements to teach ...

Someone watching the first 15 seconds of Marcos Vélez's 2-minute video announcing his plans to run for statewide office could be forgiven for assuming the first-time candidate is a Republican. The ...